Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Operating Cash Flow per Share : $1.65 (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Operating Cash Flow per Share?

Takeda Pharmaceutical Co's operating cash flow per share for the three months ended in Dec. 2023 was $0.32. Takeda Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.65.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Takeda Pharmaceutical Co was -31.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 13.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 15.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Takeda Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:

TAK' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -57.5 Med: 8.7 Max: 119
Current: 13.3

During the past 13 years, Takeda Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 119.00% per year. The lowest was -57.50% per year. And the median was 8.70% per year.

TAK's 3-Year OCF Growth Rate is ranked better than
57.5% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs TAK: 13.30

Takeda Pharmaceutical Co Operating Cash Flow per Share Historical Data

The historical data trend for Takeda Pharmaceutical Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Operating Cash Flow per Share Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.53

1.99

2.96

3.00

2.33

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.89	0.69	0.21	0.43	0.32

Competitive Comparison of Takeda Pharmaceutical Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.

Takeda Pharmaceutical Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Takeda Pharmaceutical Co's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	7310.523	/	3139.744
	=	2.33

Takeda Pharmaceutical Co's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	1017.152	/	3178.764
	=	0.32

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.65

Takeda Pharmaceutical Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.